Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo - Possible link with the reductionin chondrocyte apoptosis and caspase 3 level
Jp. Pelletier et al., Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo - Possible link with the reductionin chondrocyte apoptosis and caspase 3 level, ARTH RHEUM, 43(6), 2000, pp. 1290-1299
Objective. To evaluate the in vivo therapeutic efficacy of,N-iminorthyl-L-l
ysine (L-NIL), a selective inhibitor;or of inducible nitric oxide synthase,
on the progression of structural lesions in the experimental canine model
of osteoarthritis (OA), and to explore the effect of L-NIL on the level of
chondrocyte apoptosis and of important proteins invoiced in the apoptotic p
henomenon, i.e., caspase 3 (inducer) and Bcl-2 (inhibitor).
Methods. The OA model was created by sectioning the anterior cruciate ligam
ent. Dogs were placed into 4 experimental groups: unoperated dogs that rece
ived no treatment (controls), operated (OA) dogs that received placebo trea
tment, OA dogs that received oral L-NIL at 10 mg/kg/day and OA dogs that re
ceived oral GNU, at 1.0 mg/kg/day In both L-NIL groups, treatment started i
mmediately after surgery. The OA dogs were killed at 12 weeks after surgery
.
Results. OA dogs treated with L-NIL showed a reduction in the size of osteo
phytes and a significant decrease in the severity of macroscopic and histol
ogic cartilage lesions on both condyles and plateaus, compared with untreat
ed OA dogs, L-NIL treatment also significantly decreased metalloprotease ac
tivity in cartilage. Immunohistochemical analysis revealed that the levels
of chondrocyte apoptosis, caspase 3, and Bcl-2 were markedly increased in O
A cartilage (P < 0.0001), A positive correlation between the levels of chon
drocyte apoptosis and levels of caspase 3 was found (r = 0.54, P < 0.001).
OA dogs treated with the higher dosage L-NIL showed significantly reduced l
evels of chondrocyte apoptosis (P < 0.003) and caspase 3 (P < 0.04), but no
effect on the increased level of Bcl-2 mas demonstrated,
Conclusion. This study shows that L-NIL reduces the progression of experime
ntal OA. This effect could be related to a reduced level of chondrocyte apo
ptosis and is likely mediated by a decrease in the level of caspase 3 activ
ity. A sparing effect of L-NIL on the increased level of Bcl-2 may also be
a contributing factor.